Xiaoli Liu's most recent trade in Evelo Biosciences Inc was a trade of 24,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 27, 2021.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Evelo Biosciences Inc | Xiaoli Liu | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
Evelo Biosciences Inc | Xiaoli Liu | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 5,680 | 5,680 | - | - | Restricted Stock Units | |
Evelo Biosciences Inc | Xiaoli Jacqueline Liu | Principal Accounting Officer | Sale of securities on an exchange or to another person at price $ 5.17 per share. | 01 Dec 2020 | 3,000 | 0 (0%) | 0% | 5.2 | 15,510 | Common Stock |
Evelo Biosciences Inc | Xiaoli Jacqueline Liu | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2020 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |